1. Home
  2. LOB vs SUPN Comparison

LOB vs SUPN Comparison

Compare LOB & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOB
  • SUPN
  • Stock Information
  • Founded
  • LOB 2008
  • SUPN 2005
  • Country
  • LOB United States
  • SUPN United States
  • Employees
  • LOB N/A
  • SUPN N/A
  • Industry
  • LOB Major Banks
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOB Finance
  • SUPN Health Care
  • Exchange
  • LOB Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • LOB 2.1B
  • SUPN 1.9B
  • IPO Year
  • LOB 2015
  • SUPN 2012
  • Fundamental
  • Price
  • LOB $50.12
  • SUPN $33.84
  • Analyst Decision
  • LOB Buy
  • SUPN Hold
  • Analyst Count
  • LOB 6
  • SUPN 1
  • Target Price
  • LOB $47.83
  • SUPN $36.00
  • AVG Volume (30 Days)
  • LOB 155.5K
  • SUPN 334.5K
  • Earning Date
  • LOB 10-23-2024
  • SUPN 11-06-2024
  • Dividend Yield
  • LOB 0.24%
  • SUPN N/A
  • EPS Growth
  • LOB 74.69
  • SUPN N/A
  • EPS
  • LOB 2.44
  • SUPN 0.08
  • Revenue
  • LOB $427,450,000.00
  • SUPN $630,163,000.00
  • Revenue This Year
  • LOB N/A
  • SUPN $4.01
  • Revenue Next Year
  • LOB $16.45
  • SUPN $0.10
  • P/E Ratio
  • LOB $20.47
  • SUPN $447.14
  • Revenue Growth
  • LOB 14.14
  • SUPN N/A
  • 52 Week Low
  • LOB $26.11
  • SUPN $21.99
  • 52 Week High
  • LOB $50.57
  • SUPN $35.44
  • Technical
  • Relative Strength Index (RSI)
  • LOB 65.03
  • SUPN 63.14
  • Support Level
  • LOB $45.28
  • SUPN $31.63
  • Resistance Level
  • LOB $50.30
  • SUPN $34.21
  • Average True Range (ATR)
  • LOB 1.15
  • SUPN 0.85
  • MACD
  • LOB 0.16
  • SUPN 0.28
  • Stochastic Oscillator
  • LOB 88.92
  • SUPN 89.09

About LOB Live Oak Bancshares Inc.

Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: